The protected provisionsU.K.
This
adran has no associated
Nodiadau Esboniadol
6In paragraph 1 “protected provision of the REACH Regulation” means any of the provisions of the REACH Regulation set out in the following Table—
| Fundamental principles |
|---|
| Article 1 (aim and scope of the REACH Regulation) |
| Article 5 (the principle of “no data, no market”) |
| Article 25(1) (animal testing as a last resort) |
| Article 35 (access to information for workers) |
| Article 45 (evaluation of substances on the rolling action plan) |
| Article 48 (follow-up to substance evaluation) |
| Article 55 (the aim of Title VII, which is about authorisation of substances) |
| Article 67(1) (effect of restrictions contained in Annex XVII) |
| Article 92 or 93 (appeals) |
| Article 111, first subparagraph (formats and software for submission of information to the Agency) |
| Article 123 (communication to the public of information on risks of substances) |
| Role of the devolved administrations |
| Article 4A (the consent requirement) |
| Article 129(1) (the safeguard clause: basic principles) |
| Transparency |
| Article 54 (publication of information on evaluation) |
| Article 64(6) (publication of Agency authorisation opinions) |
| Article 72(2) (publication of Agency restriction opinions) |
| Article 77(A4) (Agency to act in a way that ensures a high degree of transparency) and (2)(e) (database(s) of registered substances) |
| Article 109 (general rules on transparency for the Agency) |
| Collaboration between the Agency and other bodies |
| Article 95 (conflicts of opinion with other bodies) |
| Article 108 (contacts with stakeholder organisations) |
| Article 110 (relations with relevant public bodies) |
| Annexes |
| The Annexes |
Commencement Information
I1Sch. 21 para. 6 in force at Royal Assent for specified purposes, see s. 147(1)(b)